# OnCo record paper-echelon-3-brentuximab-lenalidomide-rituximab-dlbcl-jco-2025 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-echelon-3-brentuximab-lenalidomide-rituximab-dlbcl-jco-2025/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-echelon-3-brentuximab-lenalidomide-rituximab-dlbcl-jco-2025" ;
  schema:name "Brentuximab vedotin combination for relapsed diffuse large B-cell lymphoma"@en ;
  schema:alternateName "ECHELON-3"@en, "Bartlett 2025"@en ;
  schema:description "Adding a CD30-directed antibody-drug conjugate to a tablet-and-antibody pairing added about five months of median survival for heavily pretreated people with relapsed aggressive lymphoma."@en ;
  schema:url <https://onco.cc/key-papers/paper-echelon-3-brentuximab-lenalidomide-rituximab-dlbcl-jco-2025/> ;
  schema:dateModified "2026-10-01"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO-24-02242>, <https://pubmed.ncbi.nlm.nih.gov/39772655/>, <https://europepmc.org/article/MED/39772655> ;
  onco:tag "lymphoma-evidence" ;
  schema:sameAs <https://doi.org/10.1200/JCO-24-02242> ;
  schema:datePublished "2025"^^xsd:gYear ;
  schema:author "Bartlett NL, Hahn U, Kim WS, et al." ;
  onco:related <https://onco.cc/roadmaps/lymphoma-roadmap/> ;
  onco:cancers <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  onco:sections <https://onco.cc/fronts/adcs/>, <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/adc/> ;
  onco:targets <https://onco.cc/targets/cd30/>, <https://onco.cc/targets/cd20/> ;
  onco:drugs <https://onco.cc/drugs/brentuximab-vedotin/>, <https://onco.cc/drugs/lenalidomide/>, <https://onco.cc/drugs/rituximab/> ;
  onco:companies <https://onco.cc/companies/pfizer/> ;
  onco:trials <https://onco.cc/trials/nct04404283/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-toxicity-qol/>, <https://onco.cc/bottlenecks/b-aging-comorbidity/> ;
  onco:journals <https://onco.cc/journals/jco/> .